Generative AI in Drug Discovery and Pharma, with Insilico Medicine (CXOTalk #782)

Generative AI in Drug Discovery and Pharma, with Insilico Medicine (CXOTalk #782)

How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorksПодробнее

How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorks

Insilico Medicine - 10 Years of AI Drug Discovery InnovationПодробнее

Insilico Medicine - 10 Years of AI Drug Discovery Innovation

Drug Discovery, Biotech, and AI with Alex Zhavoronkov, CEO, Insilico Medicine (CXOTalk #327)Подробнее

Drug Discovery, Biotech, and AI with Alex Zhavoronkov, CEO, Insilico Medicine (CXOTalk #327)

Insilico Medicine: An Extraordinary JourneyПодробнее

Insilico Medicine: An Extraordinary Journey

Generative Adversarial Networks for Drug Discovery 4x3Подробнее

Generative Adversarial Networks for Drug Discovery 4x3

AI Revolutionizes Drug Discovery: Insilico Medicine's Breakthrough!Подробнее

AI Revolutionizes Drug Discovery: Insilico Medicine's Breakthrough!

Grand Opening of Insilico Medicine's Generative AI and Quantum Computing R&D Center in Abu DhabiПодробнее

Grand Opening of Insilico Medicine's Generative AI and Quantum Computing R&D Center in Abu Dhabi

Insilico Medicine Nominates 12th PCC Targeting ENPP1Подробнее

Insilico Medicine Nominates 12th PCC Targeting ENPP1

Insilico Medicine at BIO 2022Подробнее

Insilico Medicine at BIO 2022

Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMoПодробнее

Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo

Insilico Medicine's first AI-discovered antifibrotic drug goes first-in-humanПодробнее

Insilico Medicine's first AI-discovered antifibrotic drug goes first-in-human

Generative AI for Drug Discovery and DesignПодробнее

Generative AI for Drug Discovery and Design

IMGAIA: Insilico Medicine Generative AI AnnouncementПодробнее

IMGAIA: Insilico Medicine Generative AI Announcement

How is AI transforming drug discovery? Alex Zhavoronkov, CEO, Insilico MedicineПодробнее

How is AI transforming drug discovery? Alex Zhavoronkov, CEO, Insilico Medicine

Accelerating Drug Discovery Process via Artificial Intelligence & Machine Learning #ai #mlПодробнее

Accelerating Drug Discovery Process via Artificial Intelligence & Machine Learning #ai #ml

Lantern Pharma: Redefining Oncology Drug Development with A.I. and Machine LearningПодробнее

Lantern Pharma: Redefining Oncology Drug Development with A.I. and Machine Learning

Insilico Announces Preclinical Candidate for Inhalable Formulation of Generative AI IPF DrugПодробнее

Insilico Announces Preclinical Candidate for Inhalable Formulation of Generative AI IPF Drug

События